Revolution Medicines Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
On to our next fireside chat. I'm Robert Burns, the Managing Director, and Senior Biotech Analyst at H.C. Wainwright. I am joined by Mark Goldsmith, the CEO of Revolution Medicines.
Thank you, Mark, for being here today.
Thanks, Robert. Really appreciate the opportunity.
No, of course. So why don't we just dive in. For those who may be unfamiliar with the Revolution Medicines' story? Can you provide a brief high-level overview of the company and your pipeline?
Sure. Happy to do so. Revolution Medicines is a biotech company focused entirely on RAS-addicted cancers. And that's a really important fundamental statement because by having the entire pipeline focused on the same a biologic area of focus, we developed great leverage in our know-how
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
